Amrize
NYSE: AMRZ
$49.24 ▲ +0.89  (+1.84%)
At close: Jul 24, 2026 · 3:59 PM UTC
Financial Ratios
Market Cap26.73 Bn
P/E23.45
P/S2.24
Div. Yield0.00
ROIC (Qtr)0.01
Total Debt (Qtr)5.71 Bn
Revenue Growth (1y) (Qtr)4.66
Add ratio to table…

About

Amrize Ltd is a building solutions company focused on the North American market, offering customers a broad range of advanced building solutions from foundation to rooftop. The company earns revenue from the sale of cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building solutions. Its more than 19,000 employees operate across more than 1,000 sites, facilities, and corporate offices in the United States, Canada, Colombia, Switzerland, and Jamaica…

Read more ↓
Sector: Basic Materials Industry: Building Materials CIK: 0002035989

Investment Thesis

▲ Bull case
  • Amrize is strategically positioned to capitalize on the explosive growth in data center construction, which represents a structural and long-term demand driver rather than a temporary cyclical uptick. Management highlighted that over 40% of global data center infrastructure investment through 2030 will occur in the United States, and Amrize has already supplied more than 30 data center projects in 2025 alone, with accelerating momentum into 2026. This trend is underpinned by hyperscalers rapidly expanding AI infrastructure, creating sustained demand for high-performance building solutions like Amrize’s Elevate MAX PVC roofing systems, which are specifically engineered to meet the stringent specifications of data center clients. The company’s geographic footprint and integrated supply chain allow it to serve not only the data center campuses themselves but also the surrounding infrastructure—such as power substations, water systems, and transportation networks—creating a multiplicative effect on revenue potential. Unlike residential construction, which remains interest-rate sensitive and delayed, data center demand is driven by corporate capital expenditure and technological necessity, making it far more resilient to macroeconomic fluctuations. The market is likely underestimating the durability and scalability of this tailwind, particularly as Amrize continues to win large-scale, multi-year supply agreements tied to mega-projects that provide visibility beyond quarterly volatility. This secular shift supports the company’s guidance of 4% to 6% revenue growth and 8% to 11% EBITDA expansion, as it transforms Amrize from a cyclical materials supplier into a critical enabler of the digital economy’s physical foundation.
  • The acquisition of PB Materials delivers immediate and underappreciated synergistic value that extends beyond its $180 million in annual revenue and 50-year aggregates reserves in West Texas. While management confirmed the deal is EPS and cash accretive in 2026, they did not fully emphasize how PB Materials’ ready-mix concrete network creates a vertically integrated advantage in one of North America’s fastest-growing construction corridors. West Texas is experiencing a surge in data center, energy, and logistics construction—driven by corporate relocation, renewable energy projects, and nearshoring trends—and PB Materials’ 26 operational sites (13 quarries, 13 ready-mix plants) allow Amrize to control the entire value chain from aggregate extraction to final concrete delivery. This integration reduces reliance on third-party logistics, lowers transportation costs, and improves margin stability in a region where local demand is outpacing supply. Furthermore, the acquisition adds scale to Amrize’s aggregates business in a market where pricing power is strong due to localized supply constraints and high freight sensitivity. The market may be overlooking how this tuck-in acquisition fuels Amrize’s ASPIRE program by providing additional scale for procurement synergies and logistics optimization, particularly as the company targets $250 million in savings by 2028. With antitrust clearance already secured and closure expected in Q1 2026, PB Materials is poised to contribute meaningfully to volume growth and margin expansion in Building Materials—especially as aggregates pricing is guided to rise mid-single digits on a freight-adjusted basis.
  • Amrize’s ‘Made in America’ label expansion to nine U.S. cement plants represents a quiet but powerful catalyst that aligns with evolving buyer preferences and policy tailwinds, yet received minimal emphasis in the earnings call despite its strategic relevance. The label guarantees that cement is manufactured entirely domestically—from raw materials to final product—meeting rigorous U.S. performance standards, which is increasingly critical as federal and state infrastructure projects prioritize American-made materials under Buy America provisions. This differentiation is not merely branding; it reduces supply chain risk, enhances customer trust, and positions Amrize to win public-sector contracts that mandate domestic sourcing. The company is actively investing in production increases at flagship plants like Ste. Genevieve and Midlothian as part of its $900 million 2026 CapEx plan, directly linking the label expansion to capacity growth in high-demand regions. With the U.S. cement and concrete industry contributing over $159 billion annually to the economy and supporting 577,000 jobs, Amrize’s scale as America’s top cement producer gives it unparalleled reach to leverage this trend. The market may be treating this as a marketing initiative rather than recognizing it as a structural advantage in an era of reshoring, supply chain security concerns, and government-backed infrastructure spending—factors that could drive durable pricing power and market share gains beyond current expectations.
  • The ASPIRE program is delivering tangible, scalable synergies that are still in early stages but poised to accelerate margin expansion well beyond current guidance, yet management remained vague about the specific levers and magnitude of savings during Q&A. While they confirmed a target of 70 basis points of margin expansion and $250 million in synergies by 2028, they did not detail how the $7 billion in third-party spend is being systematically addressed across logistics, raw materials, and services—despite noting early impacts in Building Materials’ Q4 results. The program’s focus on optimizing non-core expenditures through scale and supplier consolidation is particularly powerful in a fragmented industry where Amrize’s size ($11.8 billion revenue) allows it to exert pricing influence and drive efficiency gains that smaller competitors cannot replicate. Early wins in logistics and raw materials procurement suggest the model is working, and with CapEx increasing to $900 million in 2026—much of it directed toward debottlenecking plants and modernizing terminals—the operational foundation for ASPIRE to scale is being laid. The market may be underestimating how quickly these synergies can compound, especially as the company integrates PB Materials and leverages its expanded footprint to negotiate better terms with vendors. Given that ASPIRE is already contributing to margin expansion in Building Materials (up 60 basis points in Q4 2025), the potential for double-digit EBITDA growth appears conservative if the program achieves even half of its stated ambition ahead of schedule.
▼ Bear case
  • Amrize’s residential roofing segment faces persistent and underestimated structural headwinds that could delay recovery and weigh on Building Envelope performance longer than management acknowledges, despite their optimism about a second-half rebound. While the company cites pent-up demand from a housing shortage and expects gradual improvement as interest rates decline, it admitted that new residential construction volumes are not planned for any growth in 2026, relying solely on repair and refurbishment (R&R) for resilience. This is significant because R&R, while more stable, is still vulnerable to affordability pressures and labor shortages, and the company itself acknowledged an $8 million increase in warranty provisions due to rising claims activity—a signal of underlying quality or installation issues that could escalate costs. Furthermore, the Building Envelope segment experienced a temporary plant disruption in Q1 2026 that dragged down margins, and management offered no clarity on whether such disruptions could recur or how they are mitigating operational risk. The market may be ignoring the long-term threat posed by competitors like QXO, which acquired Beacon and is actively seeking to disintermediate traditional supplier-distributor relationships by working directly with contractors—a shift that could erode Amrize’s market share even if it maintains strong end-customer relationships. With residential roofing representing roughly 10% of total business (20% of Building Envelope, which is half the company), prolonged weakness here could offset gains elsewhere, especially if commercial roofing growth remains only low-single digits as guided.
  • Amrize’s aggressive capital allocation strategy—featuring $900 million in CapEx, a $1 billion share repurchase, and ongoing M&A—risks overextending its balance sheet and limiting financial flexibility if growth fails to materialize as expected, a concern underscored by rising leverage and cautious commentary on cash flow sustainability. Although the company ended 2025 with a net leverage ratio of 1.1x, it rose to 1.7x by Q1 2026 due to seasonal cash outflows and the timing of the PB Materials acquisition, highlighting how quickly leverage can increase during integration phases. Management emphasized strong cash conversion (~50%) and liquidity (~$6 billion), but they did not address how rising interest rates or a prolonged downturn in commercial or infrastructure spending could stress coverage ratios, especially with net interest expense guided at $340 million for 2026. The share repurchase program, while returning capital, reduces the cushion available for unexpected integration costs or market downturns, and the company’s limited history as an independent entity (post-spin-off in June 2025) means its resilience under stress remains untested. Furthermore, the $900 million CapEx target—more than double the growth CapEx of prior years—assumes successful execution and commercialization of volumes from projects like the Ste. Gen ramp-up and Malarkey Shingles plant; any delays in commissioning or market uptake could turn these investments into underutilized assets, dragging on returns. The market may be placing too much faith in management’s ability to execute complex capital projects while simultaneously returning cash and pursuing acquisitions, without sufficient scrutiny of execution risk.
  • Pricing power in Building Materials may be more fragile than management suggests, particularly for cement, where net pricing was down 0.8% in Q4 2025 and only low-single-digit increases are guided for 2026 despite volume growth and ASPIRE savings. While aggregates pricing showed strength (up 7.3% including freight in Q4), cement pricing remains vulnerable to regional overcapacity, import competition, and customer resistance in a commoditized market where Amrize’s inland position helps but does not guarantee pricing control. The company acknowledged that pricing has been phasing in since January with full run rate assumed by April 1, yet they offered no concrete evidence of widespread acceptance beyond isolated large projects that benefited margins during the quarter. This lack of broad-based pricing traction raises concerns that volume growth may be coming at the expense of margin, especially if customers delay purchases in anticipation of further increases or shift to lower-cost alternatives. In Building Envelope, although commercial roofing margins improved, the company admitted to disruption in residential pricing and only expects price-over-cost to improve “as we move through the year”—a vague timeline that suggests uncertainty. If pricing fails to stick, the reliance on volume and cost savings from ASPIRE to drive EBITDA growth becomes riskier, particularly as wage inflation and energy costs persist. The market may be assuming that pricing improvements are inevitable due to demand strength, but Amrize’s own data shows a mixed and inconsistent picture that warrants caution.
  • The company’s growth narrative is heavily dependent on the continued strength of commercial and infrastructure demand, yet it underplays the vulnerability of these sectors to shifts in fiscal policy, interest rates, and corporate capital expenditure cycles—factors that could reverse quickly if macroeconomic conditions deteriorate. While management pointed to federal, state, and local modernization projects and resilient commercial R&R activity, they did not address how a potential slowdown in data center spending—due to overbuilding, AI ROI uncertainty, or regulatory scrutiny—could impact demand. Similarly, infrastructure projects, though often non-discretionary, are subject to funding delays, permitting challenges, and political shifts; the emphasis on “domestic-focused agendas” in the U.S. and Canada assumes sustained bipartisan support, which is not guaranteed. The Building Envelope segment’s reliance on commercial new construction converting to roofing demand later in the project cycle introduces lag and execution risk—if those projects stall, the expected roofing uplift may not materialize. Furthermore, the company’s expectation that lower interest rates will broadly stimulate activity ignores the lag between rate cuts and actual groundbreaking, particularly for large commercial and industrial projects that require lengthy planning and financing. If the anticipated demand acceleration fails to materialize as guided, Amrize’s 4% to 6% revenue and 8% to 11% EBITDA targets could prove optimistic, leaving the market exposed to downside revisions.

Geographical Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Building Materials
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 CRH Crh Public Ltd Co 68.97 Bn17.781.8118.55 Bn
2 VMC Vulcan Materials CO 35.82 Bn-7,811.034.444.36 Bn
3 MLM Martin Marietta Materials Inc 32.98 Bn17.725.195.29 Bn
4 AMRZ Amrize Ltd 26.73 Bn23.452.245.71 Bn
5 CX Cemex Sab De Cv 17.67 Bn1,167.371.07-
6 JHX James Hardie Industries plc 14.97 Bn134.623.104.58 Bn
7 EXP Eagle Materials Inc 6.47 Bn15.492.801.76 Bn
8 KNF Knife River Corp 4.40 Bn30.021.371.43 Bn